PAR DRUGS AND CHEMICALS Financial Statement Analysis
|
||
|
The Revenues of PAR DRUGS AND CHEMICALS have decreased by -0.11% YoY .
The Earnings Per Share (EPS) of PAR DRUGS AND CHEMICALS has increased by 28.01 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
PAR DRUGS AND CHEMICALS Last 5 Annual Financial Results
[NSE : PAR]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹96 Cr | ₹96 Cr | ₹75 Cr | ₹61 Cr | ₹56 Cr |
| Expenses | ₹73 Cr | ₹78 Cr | ₹59 Cr | ₹45 Cr | ₹46 Cr |
| Operating Profit (Excl OI) | ₹23 Cr | ₹18 Cr | ₹16 Cr | ₹16 Cr | ₹9.44 Cr |
| Other Income | ₹0.24 Cr | ₹0.24 Cr | ₹0.18 Cr | ₹0.19 Cr | ₹0.10 Cr |
| Interest | ₹0.11 Cr | ₹0.13 Cr | ₹0.45 Cr | ₹0.64 Cr | ₹0.79 Cr |
| Depreciation | ₹3.44 Cr | ₹3.23 Cr | ₹3.28 Cr | ₹2.82 Cr | ₹2.76 Cr |
| Profit Before Tax | ₹20 Cr | ₹15 Cr | ₹13 Cr | ₹15 Cr | ₹5.99 Cr |
| Profit After Tax | ₹15 Cr | ₹11 Cr | ₹9.21 Cr | ₹12 Cr | ₹4.77 Cr |
| Earnings Per Share (Rs) | ₹11.79 | ₹9.21 | ₹7.49 | ₹18.87 | ₹7.75 |
| PAT Margin (%) | 13.52 | 10.46 | 10.86 | 16.81 | 7.50 |
| ROE(%) | 18.49 | 17.29 | 16.44 | 25.02 | 13.68 |
| ROCE(%) | 25.02 | 23.20 | 21.85 | 28.68 | 15.56 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.16 | 0.15 |
Key Financials |
||
| Market Cap | : | ₹ 152.8 Cr |
| Revenue (TTM) | : | ₹ 101.5 Cr |
| Net Profit(TTM) | : | ₹ 15.4 Cr |
| EPS (TTM) | : | ₹ 12.5 |
| P/E (TTM) | : | 9.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PAR DRUGS AND CHEMICALS | -16.8% | -38.8% | -40% |
| PIDILITE INDUSTRIES | 0.4% | -2.1% | 3.5% |
| SRF | 1% | 7.5% | 16.6% |
| SOLAR INDUSTRIES INDIA | 2.8% | -6.7% | 33.3% |
| GUJARAT FLUOROCHEMICALS | -0.4% | 2.9% | 4.5% |
| GODREJ INDUSTRIES | 37.2% | 32.4% | 25.1% |
| DEEPAK NITRITE | 1.7% | -15.7% | -15.5% |
| TATA CHEMICALS | -1.1% | -11.7% | -12.5% |
| HIMADRI SPECIALITY CHEMICAL | 9.4% | -11.1% | 23.7% |
PAR DRUGS AND CHEMICALS Revenues
[NSE : PAR]
| Y-o-Y | -0.11 % |
| 5 Yr CAGR | 14.39 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹96 Cr | -0.11 | |
| Mar2023 | ₹96 Cr | 27.54 | |
| Mar2022 | ₹75 Cr | 23.58 | |
| Mar2021 | ₹61 Cr | 8.78 | |
| Mar2020 | ₹56 Cr | - | |
PAR DRUGS AND CHEMICALS Operating Profit
[NSE : PAR]
| Y-o-Y | 25.33 % |
| 5 Yr CAGR | 24.68 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹23 Cr | 25.33 | |
| Mar2023 | ₹18 Cr | 12.01 | |
| Mar2022 | ₹16 Cr | 1.51 | |
| Mar2021 | ₹16 Cr | 69.58 | |
| Mar2020 | ₹9.44 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 25.45 % |
| 5 Yr CAGR | 8.99 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 23.86% | 25.45 | |
| Mar2023 | 19.02% | -12.15 | |
| Mar2022 | 21.65% | -17.87 | |
| Mar2021 | 26.36% | 55.88 | |
| Mar2020 | 16.91% | - | |
PAR DRUGS AND CHEMICALS Profit After Tax
[NSE : PAR]
| Y-o-Y | 27.94 % |
| 5 Yr CAGR | 32.08 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹15 Cr | 27.94 | |
| Mar2023 | ₹11 Cr | 23.02 | |
| Mar2022 | ₹9.21 Cr | -20.65 | |
| Mar2021 | ₹12 Cr | 143.67 | |
| Mar2020 | ₹4.77 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 29.25 % |
| 5 Yr CAGR | 15.87 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 13.52 % | 29.25 | |
| Mar2023 | 10.46 % | -3.68 | |
| Mar2022 | 10.86 % | -35.40 | |
| Mar2021 | 16.81 % | 124.13 | |
| Mar2020 | 7.5 % | - | |
PAR DRUGS AND CHEMICALS Earnings Per Share (EPS)
[NSE : PAR]
| Y-o-Y | 28.01 % |
| 5 Yr CAGR | 11.06 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹12 | 28.01 | |
| Mar2023 | ₹9.21 | 22.96 | |
| Mar2022 | ₹7.49 | -60.31 | |
| Mar2021 | ₹19 | 143.48 | |
| Mar2020 | ₹7.75 | - | |
PAR DRUGS AND CHEMICALS Return on Capital Employed (ROCE)
[NSE : PAR]
| Y-o-Y | 7.84 % |
| 5 Yr CAGR | 12.61 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 25.02% | 7.84 | |
| Mar2023 | 23.2% | 6.18 | |
| Mar2022 | 21.85% | -23.81 | |
| Mar2021 | 28.68% | 84.32 | |
| Mar2020 | 15.56% | - | |
PAR DRUGS AND CHEMICALS Share Price vs Sensex
| Current Share Price | : | ₹124.2 |
| Current MarketCap | : | ₹ 152.8 Cr |
| Updated EOD on | : | Feb 21,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PAR DRUGS AND CHEMICALS | -16.8% |
-38.8% |
-40% |
| SENSEX | -0.8% |
-1.6% |
3.1% |
PAR DRUGS AND CHEMICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about PAR DRUGS AND CHEMICALS Financials
How the annual revenues of PAR DRUGS AND CHEMICALS have changed ?
The Revenues of PAR DRUGS AND CHEMICALS have decreased by -0.11% YoY .
How the Earnings per Share (EPS) of PAR DRUGS AND CHEMICALS have changed?
The Earnings Per Share (EPS) of PAR DRUGS AND CHEMICALS has increased by 28.01 % YoY .
Check out Intrinsic Value of Peers of PAR DRUGS AND CHEMICALS
Compare Stock Analytics of Peers of PAR DRUGS AND CHEMICALS
PIDILITE INDUSTRIES LTD vs SRF LTD vs SOLAR INDUSTRIES INDIA LTD
GUJARAT FLUOROCHEMICALS LTD vs GODREJ INDUSTRIES LTD vs
PIDILITE INDUSTRIES LTD vs SRF LTD vs SOLAR INDUSTRIES INDIA LTD
GUJARAT FLUOROCHEMICALS LTD vs GODREJ INDUSTRIES LTD vs
